1. Executive Summary |
2. Global Peripheral Vascular Disease (PVD) Diagnostics Market Introduction |
2.1. Global Peripheral Vascular Disease (PVD) Diagnostics Market – Taxonomy |
2.2. Global Peripheral Vascular Disease (PVD) Diagnostics Market –Definitions |
2.2.1. By Diagnosis Type |
2.2.2. By End User |
2.2.3. By Region |
3. Global Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Peripheral Vascular Disease (PVD) Diagnostics Market Dynamic Factors - Impact Analysis |
3.6. Global Peripheral Vascular Disease (PVD) Diagnostics Market – Competition Landscape |
4. Global Peripheral Vascular Disease (PVD) Diagnostics Market Analysis,2017-2021 and Forecast, 2022-2028 |
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Peripheral Vascular Disease (PVD) Diagnostics Market, By Diagnosis Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1. Ankle-brachial index (ABI) |
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Doppler Ultrasound |
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Angiography |
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Global Peripheral Vascular Disease (PVD) Diagnostics Market Forecast, By End User, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
6.1. Hospitals & Diagnostic Labs |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Ambulatory Surgical Centers |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Peripheral Vascular Disease (PVD) Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1. North America |
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Region, 2022-2028 |
8. North America Peripheral Vascular Disease (PVD) Diagnostics Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Ankle-brachial index (ABI) |
8.1.2. Doppler Ultrasound |
8.1.3. Angiography |
8.1.4. Others |
8.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
8.2.1. Hospitals & Diagnostic Labs |
8.2.2. Ambulatory Surgical Centers |
8.2.3. Others |
8.3. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. USA |
8.3.2. Canada |
8.4. North America Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028 |
8.5. North America Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends |
9. Europe Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Ankle-brachial index (ABI) |
9.1.2. Doppler Ultrasound |
9.1.3. Angiography |
9.1.4. Others |
9.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Hospitals & Diagnostic Labs |
9.2.2. Ambulatory Surgical Centers |
9.2.3. Others |
9.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Spain |
9.3.5. Italy |
9.3.6. Russia |
9.3.7. Poland |
9.3.8. Rest of Europe |
9.4. Europe Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028 |
9.5. Europe Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends |
10. Asia-Pacific Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Ankle-brachial index (ABI) |
10.1.2. Doppler Ultrasound |
10.1.3. Angiography |
10.1.4. Others |
10.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Hospitals & Diagnostic Labs |
10.2.2. Ambulatory Surgical Centers |
10.2.3. Others |
10.3. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Japan |
10.3.2. China |
10.3.3. India |
10.3.4. ASEAN |
10.3.5. Australia & New Zealand |
10.3.6. Rest of Asia-Pacific |
10.4. Asia-Pacific Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028 |
10.5. Asia-Pacific Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends |
11. Latin America Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
11.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Ankle-brachial index (ABI) |
11.1.2. Doppler Ultrasound |
11.1.3. Angiography |
11.1.4. Others |
11.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Hospitals & Diagnostic Labs |
11.2.2. Ambulatory Surgical Centers |
11.2.3. Others |
11.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Mexico |
11.3.3. Argentina |
11.3.4. Rest of Latin America |
11.4. Latin America Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028 |
11.5. Latin America Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends |
12. Middle East and Africa Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
12.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Ankle-brachial index (ABI) |
12.1.2. Doppler Ultrasound |
12.1.3. Angiography |
12.1.4. Others |
12.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Hospitals & Diagnostic Labs |
12.2.2. Ambulatory Surgical Centers |
12.2.3. Others |
12.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Gulf Cooperation Council (GCC) Countries |
12.3.2. Israel |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028 |
12.5. MEA Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Diagnostics & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Arjo AB |
13.2.2. D. E. Hokanson Inc |
13.2.3. Fukuda Denshi Co. Ltd |
13.2.4. Koven Technology Inc |
13.2.5. Perimed AB |
13.2.6. Unetixs Vascular Inc |
13.2.7. Viasonix Ltd. |
13.2.8. BiomediX |
14. Research Methodology |
15. Key Assumptions and Acronyms |
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.